FDA’s Initial Draft Guidance on Clinical Trials with Psychedelic Drugs The U.S. Food and Drug Administration released a new draft guidance for researchers looking into psychedelic medicines to potentially treat medical illnesses, such as psychiatric or substance Read More > June 28, 2023